Dextromethorphan-Bupropion

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Major Depressive Disorder (MDD)

Drug Information

Target Indication

Major Depressive Disorder (MDD)

Clinical Trial

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

AXSM

Axsome Therapeutics, Inc.

Related Pipeline

Narcolepsy

Excessive Sleepiness

Major Depressive Disorder

Binge-Eating Disorder

Agitation in Patients With Dementia of the Alzheimer's Type

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts